NRP1 assists the binding of the S protein to ACE2 [10]; viral replication in vitro is inhibited by anti-NRP1 antibodies, indicating that NRP1 may be an effective target in COVID-19 treatment. This evidence concerns the gene ACE2 and COVID-19.